Search This Blog

Friday, January 4, 2019

Millendo Therapeutics initiated at Ladenburg


Millendo Therapeutics initiated with a Buy at Ladenburg. Ladenburg Thalmann analyst Matthew Kaplan started Millendo Therapeutics with a Buy rating and $29 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)